Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8993 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD1613 |
Approved |
0.8714 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8705 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8633 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD4908 |
Phase 1 |
0.8511 |
High Similarity |
NPD3027 |
Phase 3 |
0.8261 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8201 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8165 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7925 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7862 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7853 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7834 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7823 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7736 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD37 |
Approved |
0.7636 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7616 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7607 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7607 |
Intermediate Similarity |
NPD4966 |
Approved |
0.76 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.758 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7576 |
Intermediate Similarity |
NPD5494 |
Approved |
0.755 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7455 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7442 |
Intermediate Similarity |
NPD7240 |
Approved |
0.744 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7403 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7399 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7315 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7289 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7279 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7232 |
Intermediate Similarity |
NPD4663 |
Approved |
0.723 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7209 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7205 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7192 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7466 |
Approved |
0.717 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7169 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD228 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7159 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7113 |
Intermediate Similarity |
NPD7843 |
Approved |
0.711 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7093 |
Intermediate Similarity |
NPD27 |
Approved |
0.7093 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7079 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7071 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7044 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7024 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD290 |
Approved |
0.6994 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4675 |
Approved |
0.6988 |
Remote Similarity |
NPD4678 |
Approved |
0.6987 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6981 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.698 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD4535 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD7095 |
Approved |
0.6928 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6928 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD4140 |
Approved |
0.6923 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.691 |
Remote Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6894 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD5401 |
Approved |
0.689 |
Remote Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6887 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6887 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6885 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD3705 |
Approved |
0.6864 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6852
|
Remote Similarity |
NPD8166 |
Discontinued |